Pyxis Oncology
PYXS
PYXS
80 hedge funds and large institutions have $93.1M invested in Pyxis Oncology in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
5% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less capital invested
Capital invested by funds: $97.8M → $93.1M (-$4.7M)
Holders
80
Holding in Top 10
2
Calls
$1.66M
Puts
$18K
Top Buyers
| 1 | +$8.16M | |
| 2 | +$3.46M | |
| 3 | +$2.5M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.28M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.18M |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$1.89M | |
| 3 | -$726K | |
| 4 |
HF
HRT Financial
New York
|
-$592K |
| 5 |
Jane Street
New York
|
-$464K |